360dx

Quest Diagnostics: Adrienne Brott

Quest Diagnostics named Adrienne Brott its SVP and chief quality and regulatory affairs officer. She will oversee the firm's quality and regulatory strategy, as well as its efforts complying with US ...
360dx

Siemens Healthineers Q3 Revenues Drop With COVID-19 Testing

NEW YORK — Following extraordinary demand for rapid COVID-19 antigen testing in 2021, Siemens Healthineers reported on Wednesday that the company's fiscal third quarter COVID-19 testing revenue ...
360dx

FDA Warns Against Use of Innova Medical Group SARS-CoV-2 Antigen Test

This article has been updated to include comments sent by Innova to 360Dx on Friday. NEW YORK — The US Food and Drug Administration on Thursday requested that Innova Medical Group stop sales of its ...
360dx

Microbubbling SARS-CoV-2 Antigen Test From UPenn Moves Toward POCT Application

NEW YORK – Although their highly sensitive platform for antigen detection was developed before the COVID-19 pandemic, researchers in Ping Wang's laboratory at the University of Pennsylvania saw a ...
360dx

NIH RADx-UP Program Aims to Address COVID-19 Testing Disparities in Underserved Communities

RADx-UP is funding multiple efforts to determine how marginalized groups, such as undocumented immigrants and those in rural areas, can access testing.
360dx

BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB

NEW YORK – Opko Health's BioReference Laboratories on Thursday announced an agreement with Major League Baseball to provide COVID-19 testing for the 2021 season. The Elmwood Park, New Jersey-based ...
360dx

White House COVID Dx Goals Potentially Feasible but More Funding, Coordination Needed, Experts Say

NEW YORK – This fall the Biden administration released its 2022 Biodefense Strategy and Implementation Plan, laying out its goals for responding to future pandemics and other biological threats. The ...
360dx

New Chelex-Based Protocol Shows Potential to Reduce Cost, Time of COVID-19 Testing

NEW YORK – In an effort to help alleviate pandemic-related sample prep bottlenecks, researchers at the National Institutes of Health have developed a direct-from-sample testing protocol utilizing a ...
360dx

Slovakian Study Indicates Mass Rapid Antigen Testing Can Significantly Cut SARS-CoV-2 Spread

NEW YORK — Slovakian researchers have completed a study looking at the impact of population-wide rapid antigen testing on the prevalence of SARS-CoV-2 in that country and found that mass testing with ...
360dx

First FDA EUA for Breath-Based COVID Test in Hand, InspectIR Focusing on Commercialization

NEW YORK – After receiving the first ever Emergency Use Authorization for a SARS-CoV-2 breath test from the US Food and Drug Administration, InspectIR is planning out its next steps toward ...
360dx

Lucira Health Hits $90.5M in Q1 Revenues on Back of COVID-19 Test Sales

NEW YORK – Lucira Health reported on Thursday after the market closed that its first quarter revenues grew to $90.5 million in revenues from $4.5 million in the year-ago period. Q1 2022 revenues were ...
360dx

Switch Health, Anven Biosciences Partner on SARS-CoV-2 Test Development

NEW YORK — Canadian healthcare firm Switch Health said on Wednesday that it has partnered with Anven Biosciences to develop a new class of artificial antibodies for use in point-of-care SARS-CoV-2 ...